Jeff Gallagher works in the business of life sciences.  He serves now as Executive Director of the Alliance for Building Better Medicine which accelerates the development of the advanced pharmaceutical manufacturing and R&D cluster in Richmond/Petersburg, Virginia.  As a volunteer, Jeff serves on the Board of Directors for Virginia Bioscience Health Research Corporation (VBHRC, the Catalyst), the Advisory Board for the Fralin Biomedical Research Institute where he Chairs the Technology Transfer and Commercialization Committee, VCU Innovation Gateway Technology Review Committee, and on the Board of Grow Capital Jobs Foundation in GO Virginia Region 4.

Jeff served until 2019 as CEO of Virginia Bio, the statewide trade group of the life sciences industry.  Virginia Bio connects and supports universities, companies, entrepreneurs, investors, clinicians, service professionals and patients to accelerate the discovery, commercialization and clinical application of bioscience products and services. 

Prior to leading Virginia Bio, Jeff was a co-founder and for ten years served as VP & General Counsel for Lyotropic Therapeutics, Ashland, VA. This small specialty pharma company used its proprietary formulation technology to create new drug products for license and commercialization by mid and large pharma.  Previously, he practiced corporate law in Richmond, focusing on new technology company formation, international business, and intellectual property transactions.  He counselled multiple biotechnology-based companies, including university technology spinouts, and managed the firm’s China practice.

He holds an A.B. cum laude in Government from Harvard, a J.D. from the University of Wisconsin Law School, and an LL.M in Public International Law from the University of Virginia School of Law, where he was a Ford Foundation fellow.